HCW Biologics HCWB
NASDAQ HCWB
$0.77 -0.04 (-4.94%)
At close: Nov 13, 2026 · 4:00 PM EST

HCW Biologics (HCWB) Current Deferred Revenue (2021 - 2026)

Updated

HCW Biologics (HCWB) reported Current Deferred Revenue of $348,270 for Q2 2026, down 25.9% from the prior quarter.

Analysis

HCW Biologics (HCWB) Current Deferred Revenue (2021 - 2026) Analysis & Trends

At the end of FY2021, HCW Biologics posted Current Deferred Revenue of $1.8 million.

  • The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 HCW Biologics 1.02 Mn -4.00 Mn -93,887.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 348,270.00
Mar 31, 2026 470,000.00
Sep 30, 2022 1.80 Mn
Jun 30, 2022 314,625.00
Dec 31, 2021 1.80 Mn
Mar 31, 2021 239.00 Bn
API Access

HCW Biologics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HCWB&period=max&api_key=YOUR_API_KEY